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Summary
 
The thymus plays a critical role in the maturation and production of T lymphocytes and is a
target of infection by human immunodeficiency virus (HIV) and the related simian immuno-
deficiency virus (SIV). Using the SIV/macaque model of AIDS, we examined the early effects
of SIV on the thymus. We found that thymic infection by SIV resulted in increased apoptosis
7–14 d after infection, followed by depletion of thymocyte progenitors by day 21. A marked
rebound in thymocyte progenitors occurred by day 50 and was accompanied by increased lev-
els of cell proliferation in the thymus. Our results demonstrate a marked increase in thymic
progenitor activity very early in the course of SIV infection, long before marked declines in pe-
ripheral CD4
 
1
 
 T cell counts.
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T
 
he thymus plays a critical role in the maturation and
production of T lymphocytes (1, 2)
 
 
 
and is a target of
infection for HIV (3–5). Infection of the thymus by HIV is
thought to contribute to the depletion of CD4
 
1
 
 T lym-
phocytes and the development of AIDS (6–9). This is
thought to occur by induction of apoptosis and suppression
of thymopoiesis, which would limit production of naive T
lymphocytes (6). While the role of the thymus in T cell
homeostasis in normal healthy adults is uncertain, thymic
function is important for T cell regeneration after chemo-
therapy and presumably in conditions such as AIDS where
T cells are being destroyed in large numbers (10–12). Fur-
thermore, although T cell regeneration can occur via thy-
mic-independent pathways, production of a diverse T cell
repertoire during regeneration, a requirement for immune
competence, is dependent on the thymus (13, 14). Thus,
understanding how and when HIV causes thymic dysfunc-
tion is critical for understanding the pathogenesis of AIDS,
for optimal timing of antiviral therapy and for attempting
immune reconstitution of HIV-infected individuals.
In vivo examination of the effects of HIV on the thymus
has been largely confined to the SCID-hu mouse, and to
limited study of postmortem materials (3, 6, 15–18). These
studies have helped elucidate the cellular targets of HIV in-
fection and have demonstrated a direct effect of HIV on
thymopoiesis. However, they have not been able to address
the dynamics between peripheral T cell destruction, viral
replication, host immune response and changes in the thy-
mus, particularly early in infection. To address these issues
we have used the SIV-infected macaque model of AIDS (19).
In this study we examined the effects of a pathogenic
molecular clone of SIV,
 
1
 
 SIVmac239, on the thymus of ju-
venile macaques during the first 50 d of infection. This is
the time period during which plasma viral load appears to
predict survival (20, 21). The thymus from these animals
was examined for the presence, distribution, and immu-
nophenotype of infected cells and for changes in T lym-
phocyte progenitors, cell proliferation, and apoptosis. In
addition, changes in T cell subsets, viral load, and immune
response were examined in the peripheral blood. Within
14 d of infection, dramatic increases in apoptosis in the thy-
mus were observed associated with depletion of thymocyte
progenitors. This was followed by a rebound in thymocyte
progenitors and increased levels of cell proliferation in the
thymus by 50 d after infection (dpi). This indicates that the
thymus responds to the viral insult for at least a limited
amount of time beginning very soon after infection, long
before there are significant decreases in peripheral CD4
 
1
 
 T
cells. None of these changes were seen in animals infected
with a nonpathogenic nef deletion variant of SIVmac239
(SIVmac239
 
D
 
nef), despite the ability of this virus to cause
significant infection of the thymus.
 
1
 
Abbreviations used in this paper:
 
 dpi, days after infection; SIV, simian im-
munodeficiency virus.
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Materials and Methods
 
Animals and Viral Infections.
 
16 juvenile male rhesus macaques
(
 
Macaca mulatta
 
) between 14 and 19 mo of age were divided ran-
domly into two groups of 8 and were housed in accordance with
standards of the American Association for Accreditation of Labo-
ratory Animal Care. The investigators adhered to the “Guide for
the Care and Use of Laboratory Animals” prepared by the Com-
mittee on Care and Use of Laboratory Animals of the Institute of
Laboratory Resources, National Research Council. Before use,
the animals were negative for antibodies to HIV-2, SIV, type D
retrovirus, and Simian T cell leukemia virus type 1.
The two groups of animals were intravenously inoculated with
equal doses (50 ng of SIV p27) of closely related pathogenic
(SIVmac239) or nonpathogenic (SIVmac239
 
D
 
nef) molecular
clones of SIV. In addition, four healthy, age- and sex-matched
rhesus monkeys were killed as normal controls. Tissues from two
of the four controls were not available for flow cytometry but
were used in all other analyses. SIVmac239 is the prototypic
pathogenic molecular clone of SIV (22). SIVmac239
 
D
 
nef is a
nonpathogenic derivative of SIVmac239 with a 182-bp deletion
in the nef-unique region (23).
 
Virus Isolation.
 
Peripheral blood was collected for viral isola-
tion before inoculation and at 3, 7, 14, 21, 35, and 50 d after in-
oculation from all animals alive at those time points. Quantitative
viral cultures were performed on each blood sample as previously
described (24). In brief, serial threefold dilutions were performed
in duplicate beginning with 10
 
6
 
 PBMCs. PBMC dilutions were
cocultured with 10
 
5 
 
CEMX174 cells in a volume of 1 ml. Cul-
tures were split 1:2 twice weekly until day 21, when the cultures
were assayed for virus production by ELISA for SIV p27
(Coulter, Hialeah, FL). Results are expressed as the number of
SIV
 
1
 
 cells/10
 
6
 
 PBMCs.
 
SIV-specific Antibody Response and Plasma Antigenemia.
 
SIV-spe-
cific antibodies in serum were detected by ELISA using purified
whole SIVmac as previously described (25). The amount of SIV
p27 per ml of plasma was determined using a commercial SIV-p27
antigen capture ELISA kit (Coulter) according to the manufac-
turer’s recommendations. Antigen values 
 
$
 
0.10 ng/ml of plasma
were considered SIV antigen–positive.
 
Tissue Collection and Processing.
 
Two animals from each group
were killed at 7, 14, 21, and 50 dpi by intravenous injection of
sodium pentobarbital. Thymus and other tissues were collected in
10% neutral buffered formalin, embedded in paraffin, sectioned at
6 
 
m
 
m, and stained with hematoxylin and eosin by routine histo-
logic techniques. Adjacent sections were subjected to in situ hy-
bridization and immunohistochemistry. Adjacent blocks of fresh
tissue were collected for flow cytometry and snap-frozen for im-
munohistochemistry in optimum cutting temperature compound
(O.C.T.; Miles Inc., Elkhart, IN), by immersion in 2-methylbu-
tane cooled in dry ice.
 
Flow Cytometric Analysis of Thymocyte Progenitors.
 
Thymic tis-
sue was obtained at the time of death, minced into small frag-
ments, and then digested into a single cell suspension by incuba-
tion in PBS with 0.5 mg/ml of collagenase (Sigma Chemical Co.,
St. Louis, MO) and 2 U/ml DNase1 (Sigma Chemical Co.) at
37
 
8
 
C for 30 min with frequent agitation. The cell suspension was
then washed once in PBS with 2% normal mouse serum and fil-
tered through a 70-
 
m
 
m nylon mesh.
Antibodies used for immunophenotyping of rhesus thymocytes
included anti-CD3 (6G12; provided by J. Wong, Massachusetts
General Hospital, Boston, MA; reference 26); anti-CD4 (OKT4;
Ortho Diagnostic Systems Inc., Raritan, NJ); anti-CD8 (Leu-2a;
Becton Dickinson, San Jose, CA); and anti-CD34 (QBend-10;
Immunotech, Inc., Westbrook, ME). Cells were stained in the
presence of staining media (PBS with 2% mouse serum). After
antibody staining, the cells were fixed with fresh 2% paraformal-
dehyde. Three-color flow cytometry analysis of the cells was per-
formed using a FACScan
 
Ò
 
 with Cell Quest software (Becton
Dickinson). Appropriate isotype controls were used to establish
positive and negative gates. 20,000 events were collected from a
live gate to exclude cellular debris.
For comparison, peripheral blood from all animals was col-
lected in EDTA before inoculation and at 7, 14, 21, 35, and 50
dpi (from remaining animals) for analysis of lymphocyte subsets
CD4 (OKT4) and CD8 (Leu-2a) using a whole blood lysis tech-
nique. Samples were analyzed as above using two-color flow cy-
tometry.
 
Localization of SIV-infected Cells.
 
Localization of infected cells
was performed by immunohistochemistry for viral antigens and
by in situ hybridization for viral DNA and RNA. In situ hybrid-
ization was performed on formalin-fixed paraffin-embedded sec-
tions. The DNA probe, consisting of the entire SIVmac239 genome,
was labeled with digoxigenin-11-dUTP by random priming (Boeh-
ringer Mannheim, Indianapolis, IN) as previously described (24).
Sections were examined microscopically and scored semiquanti-
tatively on a scale of 0–4 as follows (Table 1): the absence of pos-
itive cells was given a score of 0; 1–5 positive cells per section a
score of 1; 5–10 positive cells per 10
 
3
 
 field a score of 2; 10–15
positive cells per 10
 
3
 
 field a score of 3; and 
 
.
 
15 positive cells per
10
 
3
 
 field a score of 4. Each slide was evaluated independently by
two experienced observers (M.A. Simon and A.A. Lackner) and
the score presented is the mean rounded up to the next whole
number.
Adjacent snap-frozen blocks of tissue were used in immuno-
histochemical procedures to localize virus as previously described
(27, 28). In brief, tissue sections were cut at 6 
 
m
 
m, fixed in 2%
paraformaldehyde, and immunostained using an avidin-biotin–
horseradish peroxidase complex (ABC) technique with diami-
nobenzidine as the chromogen. The primary antibody used was
Senv71.1 (SmithKline Beacham, Rixensart, Belgium), which rec-
ognizes SIV gp120. Sections were examined microscopically and
scored semiquantitatively on a scale of 0–4 as described above for
in situ hybridization and as shown in Table 1.
 
Immunophenotype of Infected Cells.
 
To examine the immunophe-
notype of infected cells we performed double-label immunohis-
tochemistry. This entailed performing immunohistochemistry for
SIV gp120 as indicated above, followed by immunohistochemis-
try for cells of the monocyte/macrophage lineage (CD68, EBM-11;
Dako Corp.) or T cells (CD2, T11; Coulter). Double labels were
performed as previously described (29, 30) using Vector
 
Ò
 
 blue
followed by Vector
 
Ò
 
 red substrates or diaminobenzidine followed
by Vector
 
Ò
 
 red (Vector Labs., Burlingame, CA).
 
Quantitation of Cell Proliferation in the Thymus.
 
To examine cell
proliferation in the thymus, 3-
 
m
 
m-thick sections were immuno-
stained using the Ki67 nuclear proliferation antigen (MIB-1; Im-
munotech, Inc.) as previously described (31). Evaluation of cell
proliferation using this antibody has been validated in several spe-
cies (31–36). Diaminobenzidine was used as the chromogen and
the slides were lightly counterstained with hematoxylin. Thus, all
nuclei were a light blue and nuclei of proliferating cells were la-
beled dark brown. This difference in staining characteristics was
used to determine the fraction of cells positive for Ki67 in the
thymus. The fraction of positive cells was measured separately in 
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the cortex and medulla in five nonoverlapping fields (527,640
 
m
 
m
 
2
 
) using an Olympus Vanox-S research microscope interfaced
to a Quantimet 570c image analyzer (Leica, Cambridge, UK) via
an Optronics DEI 750 CCD camera (Goleta, CA). The total
number of cells in a field (excluding vessels, Hassals corpuscles,
etc.) were traced and counted automatically according to a
threshold of contrast that would detect all nuclei stained with he-
matoxylin or diaminobenzidine. This threshold was determined
visually once for all sections. The positive cells were then counted
by adjusting the threshold of contrast visually (once for all sec-
tions labeled with the same antibody) so that only cells stained
with diaminobenzidine were detected. The positive cells were
then traced and counted automatically. The fraction of proliferat-
ing cells was determined by dividing the total number of labeled
cells in a field by the total number of cells in the same field. Each
field provided a single data point for construction of box-plots
and median traces (see Fig. 4).
 
Quantitation of Apoptosis in the Thymus.
 
To detect apoptotic
cells, sections of thymus adjacent to those used for evaluation of
cell proliferation were subjected to in situ end-labeling (37) using
the Apotag kit (Oncor, Inc., Gaithersburg, MD). Manufacturer’s
recommendations were followed except that the detection system
used consisted of unlabeled polyclonal sheep antidigoxigenin an-
tibody (Boehringer Mannheim) followed by biotinylated second-
ary antibody and then biotin-conjugated horseradish peroxidase
complex (Vector Labs.). Diaminobenzidine served as the chro-
mogen. This is the same detection system as used in our in situ
hybridization assays and it has been previously described (24).
The fraction of apoptotic cells in the cortex and medulla was then
quantitated as indicated above for cell proliferation.
 
Quantitation of CD4
 
1
 
 and CD8
 
1
 
 T Cells and TIA-1 Expression
in the Thymus by Morphometry.
 
To examine absolute numbers of
CD4 and CD8 single-positive T cells in the thymic medulla,
3-
 
m
 
m-thick sections were immunostained with monoclonal anti-
bodies to CD4 (Nu-Th/1; Nicheri Res Institute, Tokyo, Japan)
and CD8 (DK 25; Dako Corp.) as previously described (31). The
fraction of cells positive for CD4 and CD8 were quantitated as
described above for cell proliferation. Quantitation of CD4 and
CD8 single-positive T cells was not attempted in the thymic cor-
tex due to the high percentage of double-positive cells.
Sections of thymus (both cortex and medulla) were also immu-
nostained with monoclonal anti-TIA-1 (Coulter). TIA-1 is a 15-kd
cytotoxic granule-associated protein expressed predominantly in
natural killer cells and cytotoxic T lymphocytes and a minority of
cells of monocyte/macrophage lineage
 
 
 
(38, 39). The fraction of cells
positive for TIA-1 were quantitated as described above for cell
proliferation.
 
Data Analysis.
 
Results of the morphometric analyses were
represented graphically as box-plots and median traces. Statistical
significance of the data was assessed using regression analysis and
nonparametric tests (Kruskal-Wallis and Mann-Whitney with
Bonferroni correction) using Minitab statistical software (Minitab,
Inc., State College, PA) Regression analysis was used to test the
significance of the influence of viral inoculum (SIVmac239 versus
SIVmac239
 
D
 
nef), time (dpi), and the interaction between time
and viral inoculum on the levels of apoptosis and proliferation
observed in the thymic cortex and medulla.
 
Results
 
Animals and Viral Infections.
 
To examine the early effects
of SIV on the thymus, two groups of eight rhesus macaques
were intravenously inoculated with equal doses (50 ng of
SIV p27) of closely related pathogenic (SIVmac239) or
nonpathogenic (SIVmac239
 
D
 
nef) molecular clones of SIV
(22, 23). Two animals from each group were killed at 7, 14,
21, and 50 dpi, the thymus was collected, and adjacent blocks
of tissue were examined by histopathology, in situ hybrid-
ization, immunohistochemistry, quantitative image analysis,
and flow cytometry. Peripheral blood was collected at 3, 7,
14, 21, 35, and 50 dpi and used for analysis of cell-associ-
ated viral load, plasma antigenemia, SIV-specific immune
response, and lymphocyte subsets on all animals alive at
those time points. Four additional healthy, age- and sex-
matched rhesus monkeys were killed as normal controls.
 
SIV Isolation and Quantitation.
 
Although animals inocu-
lated with both the pathogenic molecular clone SIVmac239
(
 
n
 
 
 
5 
 
8) and the nonpathogenic SIVmac239
 
D
 
nef (
 
n
 
 
 
5 
 
8)
had virus recovered from their PBMCs within 3 d of infec-
tion, there were marked differences in viral load and plasma
antigenemia (Fig. 1). As a group, animals inoculated with
SIVmac239 had at least one log more virus in PBMCs than
did animals inoculated with SIVmac239
 
D
 
nef at every time
point examined. In addition, although animals inoculated
with SIVmac239 maintained high viral loads after the peak
 
Table 1.
 
Detection and Localization of SIV Nucleic Acid and 
Antigen in the Thymus
 
Virus
Days
pi
Animal
no.
In situ
hybridization
(cortex/medulla)
 
*
 
Immuno-
histochemistry
SIVmac239 7 277–93 1/2 0
250–93 NA/NA
 
‡
 
NA
14 285–93 1/2 1
388–93 0/1 0
21 441–93 2/4 NA
406–93 0/2 1
50 434–93 1/3 3
364–93 1/4 4
SIVmac239
 
D
 
nef 7 493–93 NA/NA 0
243–93 0/1 1
14 251–93 0/1 1
484–93 NA/NA NA
21 400–93 0/1 0
478–93 0/1 1
50 442–93 0/0 0
492–93 0/0 0
 
*
 
Cortex, thymic cortex; medulla, thymic medulla.
Viral antigen was found only in the medulla. Results of in situ hybrid-
ization for SIV nucleic acid and immunohistochemistry for SIV antigen
were quantified as follows: no positive cells 
 
5
 
 0; 1–5 positive cells per
section 
 
5
 
 1; 5–10 positive cells per 10
 
3
 
 field 
 
5
 
 2; 10–15 positive cells
per 10
 
3
 
 field 
 
5
 
 3; 
 
.
 
15 positive cells per 10
 
3 
 
field 
 
5
 
 4.
 
‡
 
NA 
 
5
 
 Tissue not available for study. 
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at 7 dpi, animals inoculated with SIVmac239
 
D
 
nef had a
progressive decline in viral loads to the limits of detection
(1 infected cell per million) by 50 dpi.
Peak plasma antigenemia in animals inoculated with
SIVmac239 occurred at 7 dpi coincident with peak cell-
associated viral load. Plasma antigenemia then rapidly de-
creased in all animals except 364–93, which demonstrated a
typical “rapid progressor” profile (40, 41) with increasing
Figure 1. Quantitative virus isolation. Cell associated viral loads (A and B) and plasma antigenemia (C and D) in animals inoculated with pathogenic
SIVmac239 (A and C) or nonpathogenic SIVmac239Dnef (B and D). Peak viral loads were seen at 7 dpi. Viral loads in animals infected with SIVmac239
were maintained at high levels, whereas viral loads in animals infected with SIVmac239Dnef declined to very low levels, by 50 dpi. Plasma antigenemia
was transient in all animals except for 364–93, which was infected with SIVmac239. This animal demonstrated a typical “rapid progressor” profile with
increasing plasma antigenemia and absence of a detectable humoral immune response. 
1771
 
Wykrzykowska et al.
 
plasma antigenemia (Fig. 1 
 
C
 
) and absence of a detectable
humoral immune response (data not shown). In contrast to
animals inoculated with SIVmac239, only one animal inoc-
ulated with SIVmac239
 
D
 
nef had detectable antigenemia.
This occurred at only one time point and at the limit of de-
tection of this assay (Fig. 1 
 
D
 
). The viral loads in animals
inoculated with SIVmac239 and SIVmac239
 
D
 
nef were
consistent with previous observations (23, 24, 27, 42).
 
Infection of the Thymus Occurs during Primary Viremia.
 
Coincident with peak viral loads at 7 dpi, virus was de-
tected in the thymus by immunohistochemistry for SIVgp120
and by in situ hybridization for SIV nucleic acid (Table 1
and Fig. 2). Most of the infected cells detected by in situ
hybridization and immunohistochemistry were present in
the thymic medulla with few positive cells evident in the
cortex consistent with previous observations (40, 43). In-
fected cells in the thymic cortex were found only in ani-
mals inoculated with SIVmac239 and only by in situ hy-
bridization. The number of infected cells detected by in
situ hybridization and immunohistochemistry in the thy-
mus changed little over the 50-d duration of the study with
consistently greater numbers of infected cells in animals
inoculated with SIVmac239 than in animals inoculated
with SIVmac239
 
D
 
nef. By 50 dpi, virus could no longer
be detected in the thymus of animals infected with
SIVmac239
 
D
 
nef.
Morphologically, two distinct populations of cells were
infected. The most numerous were small round to oval
cells, consistent with lymphocytes, and the others were
scattered, considerably larger cells that often had distinct
processes (dendritic morphology; see Fig. 2). To better de-
termine the immunophenotype of the infected cells, we
performed double-label immunohistochemistry combin-
ing detection of SIVgp120 with a marker of either mono-
cyte/macrophages (CD68) or T cells (CD2). These experi-
ments revealed that most of the infected cells in the thymic
medulla with the dendritic morphology were of monocyte/
macrophage lineage (Fig. 2). A subpopulation of SIVgp120
 
1
 
cells with dendritic morphology were negative for CD68,
suggesting that they may be of a different lineage. The ma-
jority of the SIVgp120
 
1
 
 cells, which were morphologically
compatible with lymphocytes, were labeled with the T cell
marker CD2 (data not shown).
Despite abundant evidence of SIV infection of the thy-
mus, histopathologic alterations of the thymus were mild,
consistent with previous observations during the first 8 wk
of infection (40, 43). However, we did observe an apparent
increase in the thickness of the thymic cortex in animals in-
oculated with SIVmac239 at 50 dpi compared with earlier
time points (Fig. 3). This increase in thymic cortical thick-
ness occurred coincident with increased cell proliferation in
the cortex (see below).
Figure 2. Localization of SIVmac239 in the thymus. Immunohistochemistry for SIV gp120 (A) and in situ hybridization for SIV nucleic acid (B) re-
vealed many infected cells in the thymus, particularly in the medulla. The most numerous infected cells were small round to oval cells, consistent with
lymphocytes. In addition, as shown in A, scattered cells with distinct processes were also found to be infected in the medulla. To better determine the im-
munophenotype of the cells with dendritic morphology, double-label immunohistochemistry was performed (C), combining detection of SIVgp120
(blue) with a marker of monocyte/macrophages (CD68, red). In addition to individual cells positive for CD68 only (red) or SIVgp120 only (blue), several
cells are double labeled in shades of purple due to mixing of red and blue chromogens. These purple cells are SIV-infected cells of monocyte/macrophage
lineage. At higher magnification (inset), most of the infected cells with dendritic morphology were purple, indicating that they are of monocyte/mac-
rophage lineage. Original magnification: A, 380; B, 3100; C, 375; inset, 3150.
Figure 3. Morphologic alterations of the thymus. Hematoxylin and eosin stained sections of thymus from macaques infected with SIVmac239 at 14
(A) and 50 (B) dpi and from an age-matched, uninfected macaque (C). The photomicrographs were taken at the same original magnification (333). As
compared with the uninfected control (C), moderate thinning of the cortex is visible at 14 dpi (A), whereas at 50 dpi (B) the thymic cortex is at least as
thick as in the uninfected control.1772 Early Regeneration of Thymic Progenitors after SIV Infection
Alterations in Cell Proliferation and Apoptosis in the Thymus
Occur Coincident with Early Peaks in Viral Load. To exam-
ine cell proliferation and apoptosis in the thymus, morpho-
metric analyses were performed on tissue sections using im-
munohistochemistry for the Ki-67 nuclear proliferation
antigen and TdT-mediated in situ-end labeling, respec-
tively. The Ki-67 antigen is specific for proliferating cells
found throughout the cell cycle (G1, S, G2, and M phases)
and absent in resting (G0) cells (34, 35). Analyses of cell
proliferation and apoptosis were performed separately for
the thymic cortex and medulla (Fig. 4).
In the cortex of animals inoculated with SIVmac239, the
proportion of apoptotic cells was increased by 7 dpi com-
pared with age-matched, uninfected controls and reached a
peak at 14 dpi before decreasing to normal levels at 21 and
50 dpi. This increase in apoptosis mirrored, or was slightly
delayed relative to, the early peaks in cell-associated viral
load and plasma antigenemia (7 dpi, Fig. 1). The levels of
apoptosis in the thymic cortex of animals inoculated with
SIVmac239Dnef were not statistically significantly differ-
ent from those observed in uninfected controls (P 5
0.6478). Regression analysis was used to test the signifi-
cance of the influence of viral inoculum (SIVmac239
versus SIVmac239Dnef), time (dpi), and the interaction
between time and viral inoculum on the observed levels
of apoptosis. Both time (P ,0.0005) and viral inoculum
(P ,0.0005) significantly influenced the levels of apoptosis.
The interaction of time and viral inoculum also significantly
(P ,0.0005) influenced the levels of apoptosis. The inter-
action between time and viral inoculum can be seen in Fig.
4. The increase in apoptosis cannot be attributed to a stress
response because all animals were housed and handled
Figure 4. Apoptosis and cellu-
lar proliferation in the thymus
during SIV infection. Alter-
ations in cell proliferation and
apoptosis in the thymic cortex
and medulla were examined by
morphometry in sections of thy-
mus from animals infected with
pathogenic SIVmac239 or non-
pathogenic SIVmac239Dnef and
compared with four uninfected
control animals. Results are illus-
trated as box-plots and median
traces. The box plots are based
on 10 observations (20 for the
controls), 5 from each animal.
Each box-plot represents pooled
data from two animals infected
with the same virus or four unin-
fected age-matched controls. To
examine cell proliferation, the
fraction of cells positive for the
Ki67 nuclear proliferation anti-
gen were measured separately in
the cortex and medulla using a
Quantimet 570c image analyzer.
The fraction of cells undergoing
apoptosis was similarly deter-
mined after sections were sub-
jected to in situ end labeling us-
ing the Apotag kit. The most
dramatic changes occurred in the
thymic cortex of animals infected
with SIVmac239, where there
was an increase in apoptosis at 14
dpi followed by an increase in
proliferation at 21–50 dpi. Note
that the scale of the Y axis for
proliferation in the thymic cor-
tex goes to 1, indicating that at
21 and 50 dpi nearly all of the
cells in the cortex were prolifer-
ating. With the exception of an
early increase in proliferation in
the cortex, animals infected with
SIVmac239Dnef showed no sig-
nificant differences from the un-
infected control group.1773 Wykrzykowska et al.
identically. Furthermore, serum cortisol levels showed no
significant differences among the groups or over time (data
not shown).
Proliferation in the cortex was significantly elevated in
all SIV-infected animals by 7 dpi and then rapidly de-
creased to the normal range. This early increase in prolifer-
ation occurred during peak cell-associated viral load and
plasma antigenemia. The level of proliferation in animals
inoculated with SIVmac239 then rapidly increased be-
tween 14 and 21 dpi and stayed at a high level. In contrast,
proliferation in the thymic cortex of animals inoculated
with SIVmac239Dnef, which had progressively less virus
over time, remained low. Similar to apoptosis, regression
analysis showed that proliferation in the cortex was signifi-
cantly influenced by the viral inoculum (P 5 0.010), time
after infection (P ,0.0005), and the interaction between
time and inoculum (P ,0.0005).
Levels of apoptosis and cell proliferation in the thymic
medulla (Fig. 4) mirrored the findings in the thymic cortex
but were more subtle with a consistently smaller fraction of
cells positive for each measure. As in the thymic cortex, no
significant differences in apoptosis were observed between
animals inoculated with SIVmac239Dnef and controls. In
addition, as in the thymic cortex, regression analysis showed
a significant influence of viral inoculum and time after infec-
tion on levels of apoptosis (virus, P ,0.0005; time, P ,0.0005)
and cell proliferation (virus, P 5 0.004; time, P ,0.0005).
Consistent with the observed increase in the fraction of
proliferating cells detected by image analysis, we also ob-
served an increase in forward light scatter by flow cytome-
try in thymocytes obtained from animals infected with
SIVmac239 at 21 and 50 dpi as compared with uninfected
controls or animals infected with SIVmac239Dnef (data not
shown). A subjective increase in the numbers of mitotic
figures in the thymic cortex was also observed by routine
histology.
In addition to the changes that occurred over time, sta-
tistically significant differences were found between the
pooled group of SIVmac239-infected animals (n 5 8) and
age-matched, uninfected controls (n 5 4) with respect to
proliferation or apoptosis in the thymic cortex or medulla
(P ,0.001 for all measures). Furthermore, highly signifi-
cant differences were also found between the pooled group
of SIVmac239-infected animals (n 5 8) and animals in-
fected with SIVmac239Dnef (n 5 8) with respect to these
same measures (P ,0.0001 for proliferation or apoptosis in
the thymic cortex or medulla). In contrast, no significant
differences were found between the control group (n 5 4)
Figure 5. T lymphocyte pro-
genitors in the thymus. Flow cy-
tometric analysis of thymocyte
progenitors was performed on
single cell suspensions of thymus
collected at the time of euthanasia.
Three-color flow cytometry was
performed with antibodies to sur-
face CD3, CD4, CD8, and CD34.
The figure shows the propor-
tion of positive cells for controls
and for animals infected with
SIVmac239 or SIVmac239Dnef
at each time point. Bar heights
indicate mean percentage of pos-
itive cells and whiskers above
bars show one SEM. Animals in-
fected with SIVmac239 had a de-
crease in both CD341 and CD41
CD81 populations through d 21
followed by a dramatic rebound
by 50 dpi. Marked changes in
CD4 and CD8 single-positive
cells were also seen in the thy-
mus in animals infected with
SIVmac239 including a striking
increase in CD42CD81 cells
through d 21 and a marked de-
crease in the relative percentage
of both CD4 and CD8 single-
positive cells by d 50. The latter
is likely due to the relative in-
crease in the percentage of CD341
and CD41CD81 T cell progeni-
tors. Animals infected with
SIVmac239Dnef showed few
significant changes with the ex-
ception of an increase in CD341
cells at 14 dpi.1774 Early Regeneration of Thymic Progenitors after SIV Infection
and the group infected with SIVmac239Dnef (n 5 8) for
either proliferation or apoptosis in the thymic cortex or
medulla (P $0.1502 for all measures).
To assess a possible role of T cell–mediated cytotoxicity
in the increase in apoptosis, sections of thymus adjacent to
those used for quantitation of apoptosis and proliferation
were immunostained for TIA-1, and the proportion of
positively stained cells was determined by morphometry.
TIA-1 is a cytotoxic granule-associated protein found pre-
dominantly in natural killer cells and cytotoxic T lympho-
cytes and a minority of cells of the monocyte/macrophage
lineage (38, 39). No change in the fraction of TIA-1 posi-
tive cells was observed over time or among the groups in
either the thymic cortex or medulla.
Changes in Thymocyte Progenitors Correlate with Changes in
Cell Proliferation and Apoptosis. Samples of thymus adja-
cent to those used for viral localization and quantitation of
cell proliferation and apoptosis were analyzed by multipa-
rameter flow cytometry using antibodies specific for CD3,
4, 8, and 34. The relative percentage of CD341 progenitor
cells, and to a lesser extent CD41CD81 cells, decreased
through 21 dpi in animals inoculated with SIVmac239, as
shown in Fig. 5. The decrease in thymic progenitors oc-
curred immediately after peak levels of apoptosis in the
thymus (Fig. 4). By 50 dpi, a marked rebound in the per-
centage of CD341 progenitors was seen that occurred co-
incident with a marked increase in cell proliferation in the
thymic cortex (Fig. 4).
Significant alterations in the relative percentage of CD4
and CD8 single-positive lymphocytes were also observed
in SIVmac239-infected animals (Fig. 5). Most striking was
the increase in CD81CD42 cells through 21 dpi and the
marked decrease in both CD4 and CD8 single-positive
cells by 50 dpi, which is probably due, at least in part, to
the relative increase in the CD41CD81 and CD341 cells,
resulting in a relative decrease of single-positive cells. At
the time of CD341 rebound in the thymus, a high percent-
age of the CD341 cells also coexpressed CD4 and CD8
(data not shown) as has been previously described in hu-
mans (44). Despite these significant shifts in the percentages
of CD341, CD41CD81, and CD4 and CD8 single-posi-
tive cells, the percentages and absolute numbers of CD4
and CD8 cells in the peripheral blood of these same animals
had changed little (Fig. 6).
In contrast to animals inoculated with SIVmac239, ani-
mals inoculated with SIVmac239Dnef had minimal changes
in the relative percentages of all subsets of cells examined in
the thymus, which agrees with the lack of significant
changes in cell proliferation and apoptosis observed by
morphometric analyses (Figs. 4 and 5). The one exception
was an increase in the percentage of CD341 cells at 14 dpi
(Fig. 5). This occurred immediately after a transient in-
crease in proliferation in the thymic cortex at 7 dpi (Fig. 4),
which also coincided with peak viremia.
To further examine the influence of the relative increase
in CD41CD81 and CD341 cells on percentages of single-
positive cells, we performed morphometric analyses of the
proportion of cells positive for CD4 or CD8 by immuno-
histochemistry in the thymic medulla. These morphomet-
ric data did not show a statistically significant decrease in
CD4 or CD8 cells, although there was a trend toward a
smaller proportion of CD41 cells with increasing time in
animals infected with SIVmac239 (data not shown). Thus,
the decrease in the percentage of CD4 and CD8 single-
positive cells observed in the thymus by flow cytometry
would appear to be due to the increase in thymic progeni-
tors (CD41CD81 and CD341). However, this analysis was
limited to the thymic medulla due to the high percentage
of CD41CD81 cells in the thymic cortex.
Discussion
Our study demonstrates that the thymus is not only a
primary target of SIV infection but that significant changes
Figure 6. Flow cytometric
analysis of peripheral blood leu-
kocytes in animals before and af-
ter infection with SIVmac239 or
SIVmac239Dnef. Animals inocu-
lated with SIVmac239 show a
mild decline in CD4/CD8 ratio
associated with a minimal de-
crease in CD41 T cells and a
small increase in CD8 cells. No
significant alterations in CD41
or CD81 T cell numbers, per-
centages, or CD4/CD8 ratios
were observed in animals inocu-
lated with SIVmac239Dnef.1775 Wykrzykowska et al.
in cell proliferation, apoptosis, and percentages of T cell
precursors occur very early in the thymus coincident with
the presence of infected cells and primary viremia. Of par-
ticular interest was the marked rebound in T cell progeni-
tors (CD341 and CD41CD81, Fig. 5) accompanied by in-
creased levels of cell proliferation in the thymus (Fig. 4).
This occurred in the face of persistent high-level virus rep-
lication (Fig. 1 and Table 1) and provides strong evidence
that the thymus has significant regenerative capacity through
at least the first 7 wk of infection. However, by 24 wk of
infection, morphologic evidence of severe thymic damage
is evident in most SIV-infected animals, but can also occur
earlier in rapid progressors as previously described (40, 43).
Similarly, severe thymic damage is a consistent feature of
advanced HIV infection, and a more rapid progression to
AIDS has been observed in HIV-infected children with ev-
idence of early thymic dysfunction (45). Thus the regener-
ative capacity of the thymus is clearly limited in the face of
HIV infection.
The length of this apparent early window of time during
which the thymus can regenerate is of increasing impor-
tance with the advent of potent multidrug therapies for
HIV. These multidrug therapies have been remarkably suc-
cessful in decreasing viral loads and partially restoring or
maintaining CD41 T cell numbers. However, our data im-
ply that if combination drug therapy for HIV is not started
early enough in infection, T cell regeneration will occur
with minimal help of the thymus, resulting in a limited T
cell repertoire. Indeed, Connors et al. (46) have recently
shown that disruptions of the CD41 T cell repertoire asso-
ciated with HIV infection are not initially corrected by
combination antiviral or immune-based therapies. More-
over, the initial rebound of CD41 T cells after potent com-
bination antiretroviral therapy appears to consist primarily
of memory cells. However, increases in naive CD41 T cells
may occur after prolonged therapy or in patients who have
maintained naive cells (46, 47). Finally, there are several re-
cent reports of patients on multidrug therapies with rela-
tively high CD4 counts developing opportunistic infections
(48, 49). These findings, in conjunction with those of
Mackall et al. (13) further support the concept that a func-
tional thymus is critical for regeneration of a diverse T cell
repertoire in HIV-infected patients.
The increased apoptosis in the thymus and initial deple-
tion of thymocyte progenitors in animals infected with
SIVmac239 occurred soon after peak viral loads in the
blood and coincident with localization of virus to the thy-
mus, suggesting a causal relationship. However, it is not
clear whether these changes are due to direct effects, such
as viral infection of thymic progenitors and loss of infected
cells due to the cytopathic effects of the virus, or indirect
effects via the induction of programmed cell death in “by-
stander cells.” Studies using the HIV-infected SCID-hu
mouse model have also implicated at least two mechanisms:
induction of programmed cell death in uninfected thy-
mocytes and interruption of thymopoiesis by direct infec-
tion and destruction of thymocyte progenitors (6, 15, 16).
Furthermore, the immune response is likely to play a role
in these processes via the action of natural killer cells and
cytotoxic lymphocytes directed at infected cells. However,
no increase in the proportion of cells expressing TIA-1 was
found in the thymus, which would be expected if increased
numbers of cytotoxic lymphocytes or natural killer cells
were present. However, expression of TIA-1 is not anti-
gen-specific, and so although the fraction of TIA-1–express-
ing cells did not increase, the number of SIV-specific cyto-
toxic lymphocytes may have increased.
For a direct effect, virus would presumably need to in-
fect immature thymocytes that reside primarily in the cor-
tex. Although viral infection of the thymic cortex could be
demonstrated by in situ hybridization, all of the cells de-
tected by immunohistochemistry, and most of the cells de-
tected by in situ hybridization, were in the thymic medulla.
Thus, although virus was present in the cortex where the most
dramatic morphometric and immunophenotypic changes
were observed, these alterations occurred in the absence of
detectable viral protein. This would suggest that both di-
rect and indirect mechanisms of thymocyte depletion are
involved.
These findings may have important implications for T
cell homeostasis. Despite the dramatic shifts in apoptosis,
cell proliferation, and percentages of CD341, CD41CD81,
and CD4 and CD8 single-positive cells in the thymus, the
percentages and absolute numbers of CD4 and CD8 cells in
the peripheral blood of these same animals changed little
over the 50-d period (Fig. 6). This suggests that the thymus
responds very rapidly to increased demand for T cells in the
periphery by increasing production (increased cell prolifer-
ation, and thymocyte progenitors by 50 dpi) of mature T
cells in order to maintain T cell numbers in the peripheral
blood. Moreover, evidence of increased demand for T cells
comes from recent studies using in vivo bromodeoxyuridine
labeling by Rosenzweig et al., who have shown that, com-
pared with normal macaques, rates of T cell turnover in chron-
ically SIV-infected macaques are increased two- to three-
fold for both CD41 and CD81 T cells (50). This “opening
of the tap” to compensate for increased T cell turnover (the
open drain) in HIV infection has been previously suggested
by Ho et al. (12). In future studies it will be important to
determine how long the thymus can continue to contribute
to T cell regeneration beyond the 50 d of this study.
In contrast to animals infected with SIVmac239, animals
inoculated with the same dose of the nonpathogenic nef
deletion derivative of SIVmac239, SIVmac239Dnef, caused
few if any detectable changes in cell proliferation, apopto-
sis, or thymocyte progenitors despite the presence of in-
fected cells in the thymus. Although the differences may
reflect the higher viral loads in SIVmac239-infected ani-
mals, at the peak of viremia (7 dpi) differences were not as
pronounced between the groups (z10-fold difference) as at
latter time points (z1,000-fold difference). Moreover, in-
dividual animals in each group had equivalent viral loads
(e.g., 434–93 infected with SIVmac239 and 492–93 in-
fected with SIVmac239Dnef each had 365 viral infected
cells/106 PBMCs at 7 dpi). Thus, these differences may be
attributed, at least in part, to the presence of a functional nef1776 Early Regeneration of Thymic Progenitors after SIV Infection
gene. This could occur via the effects of nef on signal trans-
duction and activation of T cells (51). Thymocyte matura-
tion involves a complex series of developmental stages all of
which involve signal transduction from the cell surface to
the nucleus. If nef is able to alter signal transduction in im-
mature thymocytes, as it apparently does in mature T cells,
it could result in inappropriate cell activation and pro-
grammed cell death.
This study shows clear and dramatic effects of SIV infec-
tion on the thymus. After an initial increase in apoptosis
and loss of thymocyte progenitors, a marked rebound in
cell proliferation and regeneration of T cell progenitors was
seen. The duration of this rebound and the cellular mecha-
nisms responsible for increased cell death in the thymus of
SIV-infected macaques are important areas for future study.
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